As the “powerhouse of the cell,” mitochondria play a critical role in cell viability through a multitude of functions — from energy converting to cell signaling and beyond. …

Navigating Biotech Funding Dynamics: Shifts in Public and Private Finance Today, we are living through what many believe is the most exciting era in the biotech industry, an era characterized by an accelerated pace of innovation where disruptive technological and scientific advancements are enabling the discovery and development of disruptive…

Does access to seamless data matter in healthcare? To best answer this question, consider these two scenarios for patients with the same condition. Patient 1 is prescribed a new drug and picks it up at his local pharmacy. They begin to have side effects, but it takes weeks to…

Central nervous system (CNS) diseases, which include neurodegenerative disorders and neuropsychiatric illnesses, have placed a significant burden on healthcare systems worldwide. Reports show that neurological disorders accounted for 16% of total deaths globally in 2016, while psychiatric diseases and mental disorders were attributable to 14% of deaths worldwide in 2015…

The significant increase in drug prices over the past several decades has become a major challenge facing patients in the U.S. In 1990, prescription drug expenditure in the U.S. totaled $40 billion. This expenditure has since increased to over $350 billion in 2020, an almost 9-fold increase, or a 7.5%…

I sat down with Chris Gibson, Co-Founder and CEO of Recursion, off the heels of their recent IPO, to talk about his journey transforming the life science industry. …

When Mubadala Capital launched its ventures platform in San Francisco three years ago, we had a simple mission: partner early with founders who want to build globally enduring companies and support them throughout their journey by leveraging Mubadala’s global assets and resources. One of the most critical industries undergoing a…